Keyphrases
Absolute Neutrophil Count
11%
Advanced Ovarian Cancer
29%
Advanced Stage
18%
Cancer Cases
14%
Cancer Patients
20%
Cancer Stage
19%
Carbohydrate Antigen 125 (CA125)
41%
Carboplatin-paclitaxel
19%
Caspase-3
11%
Cervical Cancer
74%
Cervical Cancer Patients
22%
Chemotherapy
38%
Cisplatin
20%
Endometrial Cancer
17%
Endometriosis
34%
Epithelial Ovarian Cancer
70%
Hematologic
12%
Hemoglobin
16%
Human Tissue Kallikrein
19%
Indonesia
68%
Indonesian
13%
Jakarta
58%
Knowledge Attitude
28%
Knowledge Practices
19%
Large Tumors
13%
Lymphovascular Space Involvement
12%
Magnetic Resonance Imaging
20%
Metastasis
19%
Myometrial Invasion
20%
Obstetrics and Gynaecology
13%
Odds Ratio
14%
Older Women
13%
Omental Metastasis
19%
Omentum
12%
Ovarian Cancer
47%
Ovarian Cancer Patients
23%
Ovarium
19%
Overall Survival
18%
Pada
19%
Papillomavirus Infections
19%
Prognostic Factors
15%
Quality of Life
14%
Radiotherapy
17%
Radiotherapy Response
21%
Stage IA2
13%
Stage IB
13%
Tumor
18%
Tumor Diameter
13%
Urban Community
19%
Women of Reproductive Age
13%
Medicine and Dentistry
Acetic Acid
19%
Adenocarcinoma
10%
Adverse Outcome
11%
Age Distribution
11%
Attitude
19%
Biological Marker
12%
CA-125
50%
Cancer
52%
Cancer Staging
14%
Cervical Cancer
77%
Community Health
9%
Cross Sectional Study
14%
Cytoreductive Surgery
19%
Debulking Surgery
19%
Dentistry
9%
Diagnosis
42%
Diffusion MRI
13%
Disease
28%
Endometrial Cancer
28%
Endometriosis
19%
Gynecology
23%
Hematology
9%
Histopathology
26%
Human Tissue
19%
Immunohistochemistry
11%
Krukenberg Tumor
100%
Laparoscopy
11%
Lymph Duct
9%
Magnetic Resonance Imaging
23%
Malignant Neoplasm
16%
Metastatic Carcinoma
37%
Neoplasm
40%
Obstetrics
10%
Omentum
11%
Ovarian Cancer
59%
Ovarian Tumor
10%
Overall Survival
13%
Pelvis
15%
Precancerous Condition
21%
Prevalence
19%
Primary Health Care
19%
Prognostic Factor
12%
Radiation Therapy
28%
Retrospective Study
24%
Sensitivity and Specificity
11%
Side Effect
10%
Squamous Cell Carcinoma
15%
Tissue Kallikrein
19%
Uterine Cervix
19%
Uterine Tube Carcinoma
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acetoacetic Acid
9%
Adverse Outcome
9%
Age Distribution
11%
Biological Marker
11%
C Reactive Protein
7%
Cancer Staging
25%
Carboplatin
19%
Caspase 3
12%
Cell Culture
9%
Chemoradiation Therapy
9%
Chemotherapy
45%
Cisplatin
20%
Cross-Sectional Study
16%
Cyclophosphamide
9%
Deterioration
10%
Diabetes Mellitus
9%
Disease
14%
Disease Marker
9%
Dispase
6%
Endometriosis
19%
Endometrium Cancer
9%
Female Genital Tract Cancer
10%
Immune Checkpoint Inhibitor
9%
Inflammation
9%
Insulin Resistance
9%
Malignant Neoplasm
44%
microRNA 200c
9%
Nabumetone
9%
Neoplasm
25%
Ovary Cancer
63%
Ovary Carcinoma
51%
Ovary Tumor
33%
Overall Survival
9%
Paclitaxel
19%
Papillomavirus Infection
9%
Pelvis Pain Syndrome
9%
Potassium Acetate
20%
Precancer
21%
Prevalence
20%
Randomized Controlled Trial
9%
Retrospective Study
13%
Side Effect
22%
Squamous Cell Carcinoma
18%
Survival Rate
11%
Tissue Kallikrein
9%
Tumor Marker
6%
Uterine Cervix Cancer
87%